Ligand Pharmaceuticals, Inc. (LGND)
190.20
-4.96
(-2.54%)
USD |
NASDAQ |
Dec 30, 16:00
190.09
-0.11
(-0.06%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (Quarterly): 21.02M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.552B |
| Johnson & Johnson | 3.693B |
| Inspire Medical Systems, Inc. | 24.21M |
| Elanco Animal Health, Inc. | 89.00M |
| Alnylam Pharmaceuticals, Inc. | 358.81M |